A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Treatment of COVID-19 patients using plasma therapy: Letter to Editor
2020
Journal of Birjand University of Medical Sciences
The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains antibodies against the virus. Following of the plasma therapy have not been reported any serious side
doi:10.32592/jbirjandunivmedsci.2021.28.1.109
fatcat:y7b4uuy6qbf2xpo5uddsurzpbq